MHC-restricted phosphopeptide antigens: preclinical validation and first-in-humans clinical trial in participants with high-risk melanoma (Q94568859)
Jump to navigation
Jump to search
scientific article published on 01 May 2020
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | MHC-restricted phosphopeptide antigens: preclinical validation and first-in-humans clinical trial in participants with high-risk melanoma |
scientific article published on 01 May 2020 |
Statements
MHC-restricted phosphopeptide antigens: preclinical validation and first-in-humans clinical trial in participants with high-risk melanoma (English)
Kara L Cummings
Gina R Petroni
Angela L Ambakhutwala
Kimberly A Chianese-Bullock
Kelly T Smith
Amanda Lulu
Nikole Varhegyi
Mark E Smolkin
Paisley Myers
Keira E Mahoney
Jeffrey Shabanowitz
Nico Buettner
Emily H Hall
Kathleen Haden
Mark Cobbold
Donald F Hunt
Geoffrey Weiss
Elizabeth Gaughan
Craig L Slingluff